ABIVAX Pink Sheet Performance
| AAVXF Stock | USD 18.21 0.00 0.00% |
On a scale of 0 to 100, ABIVAX Socit holds a performance score of 5. The firm shows a Beta (market volatility) of 0.3642, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, ABIVAX Socit returns are expected to increase less than the market. However, during the bear market, the loss on holding ABIVAX Socit will be expected to be smaller as well. By evaluating ABIVAX Socit Anonyme technical indicators, you can at this time evaluate if the expected return of 0.2% will be sustainable into the future. Please makes use of ABIVAX Socit Anonyme coefficient of variation, maximum drawdown, as well as the relationship between the Maximum Drawdown and day typical price to make a quick decision on whether ABIVAX Socit price patterns will revert.
ABIVAX Performance
5 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in ABIVAX Socit Anonyme are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite nearly unfluctuating basic indicators, ABIVAX Socit may actually be approaching a critical reversion point that can send shares even higher in October 2023. ...more
| Begin Period Cash Flow | 29.3 M | |
| Total Cashflows From Investing Activities | -1.5 M |
ABIVAX |
ABIVAX Socit Relative Risk vs. Return Landscape
If you would invest 1,650 in ABIVAX Socit Anonyme on June 23, 2023 and sell it today you would earn a total of 171.00 from holding ABIVAX Socit Anonyme or generate 10.36% return on investment over 90 days. ABIVAX Socit Anonyme is currently producing 0.1978% returns and takes up 2.941% volatility of returns over 90 trading days. Put another way, 25% of traded pink sheets are less volatile than ABIVAX, and 97% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
ABIVAX Socit Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for ABIVAX Socit's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as ABIVAX Socit Anonyme, and traders can use it to determine the average amount a ABIVAX Socit's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0672
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | AAVXF | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.94 actual daily | 25 75% of assets are more volatile |
Expected Return
| 0.2 actual daily | 3 97% of assets have higher returns |
Risk-Adjusted Return
| 0.07 actual daily | 5 95% of assets perform better |
Based on monthly moving average ABIVAX Socit is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ABIVAX Socit by adding it to a well-diversified portfolio.
ABIVAX Socit Fundamentals Growth
ABIVAX Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of ABIVAX Socit, and ABIVAX Socit fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on ABIVAX Pink Sheet performance.
| Return On Equity | -12.86 | |||
| Return On Asset | -0.44 | |||
| Current Valuation | 165.28 M | |||
| Shares Outstanding | 22.3 M | |||
| Price to Earning | (7.88) X | |||
| Price to Book | 27.57 X | |||
| Price to Sales | 20.65 X | |||
| Revenue | 37 K | |||
| EBITDA | (42.25 M) | |||
| Cash per Share | 1.58 X | |||
| Debt to Equity | 8.03 % | |||
| Cash Flow from Operations | (45.66 M) | |||
| Earnings Per Share | (2.59) X | |||
| Total Asset | 110.36 M | |||
About ABIVAX Socit Performance
To evaluate ABIVAX Socit Anonyme Pink Sheet as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when ABIVAX Socit generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare ABIVAX Pink Sheet's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand ABIVAX Socit Anonyme market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents ABIVAX's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.ABIVAX Socit Anonyme discovers and optimizes drugs for the treatment of inflammatory diseases, infectious diseases, and cancer in France. The company was incorporated in 2013 and is headquartered in Paris, France. Abivax Sa is traded on OTC Exchange in the United States.Things to note about ABIVAX Socit Anonyme performance evaluation
Checking the ongoing alerts about ABIVAX Socit for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for ABIVAX Socit Anonyme help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| ABIVAX Socit Anonyme has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 37 K. Net Loss for the year was (41.36 M) with loss before overhead, payroll, taxes, and interest of (45.52 M). | |
| ABIVAX Socit Anonyme has accumulated about 26.57 M in cash with (45.66 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.58. | |
| Roughly 57.0% of the company shares are held by institutions such as insurance companies |
- Analyzing ABIVAX Socit's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether ABIVAX Socit's stock is overvalued or undervalued compared to its peers.
- Examining ABIVAX Socit's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating ABIVAX Socit's management team can have a significant impact on its success or failure. Reviewing the track record and experience of ABIVAX Socit's management team can help you assess the company's leadership.
- Pay attention to analyst opinions and ratings of ABIVAX Socit's pink sheet. These opinions can provide insight into ABIVAX Socit's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ABIVAX Socit Anonyme. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in banks. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Complementary Tools for ABIVAX Pink Sheet analysis
When running ABIVAX Socit's price analysis, check to measure ABIVAX Socit's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ABIVAX Socit is operating at the current time. Most of ABIVAX Socit's value examination focuses on studying past and present price action to predict the probability of ABIVAX Socit's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ABIVAX Socit's price. Additionally, you may evaluate how the addition of ABIVAX Socit to your portfolios can decrease your overall portfolio volatility.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Global Correlations Find global opportunities by holding instruments from different markets |